For the most common type of lung cancer in Americans, deaths are falling faster than new cases, a new study reports, suggesting — but not proving — that new therapies targeting genetic mutations are having an outsize effect on survival.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,